News

The agreement provides for a close working relationship between Genzyme and Arecor in developing stable, high strength formulations of labile biomolecules. Both the parties said that the agreement

Xoma said that one of the patents covers methods of treating type 2 diabetes with high affinity antibodies and antibody fragments that bind to IL-1 beta, including Xoma

The study, funded by NIAID, is designed to test the efficacy of AEOL 10150, as measured by survival advantage, as a treatment for damage to the GI tract

Clobex is a topical steroid indicated to treat moderate to severe plaque psoriasis in patients 18 years and older. Clobex Spray comes in 2oz and 4.25oz bottles with

BAL30072 is a new siderophore sulfactam antibiotic. The penicillin-binding-protein inhibition and its bactericidal mode of action confer potent in-vitro and in-vivo activity against Gram-negative bacteria. Pathogens such as

Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease

According to a research conducted by a group of scientists in partnership with professor Michael Krainer, director of the molecular genetics working group, department of oncology, University Clinic

Earlier, COTI had entered into this partnership to advance its HIV-1 integrase inhibitor program. As per the agreement, COTI retains all data and intellectual property ownership of the

Prograf is prescribed to prevent organ rejection in patients receiving allogenic liver, kidney, or heart transplants and was first approved and launched in Japan in 1993. Prograf is